Massachusetts Financial Services CO Precision Biosciences Inc Transaction History

Massachusetts Financial Services CO

  • $321 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$1.15 - $3.34 $186,241 - $540,909
-161,949 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$2.96 - $7.76 $152,206 - $399,026
51,421 Added 46.52%
161,949 $499,000
Q4 2021

Feb 10, 2022
BUY
$7.4 - $11.66 $817,907 - $1.29 Million
110,528 New
110,528 $818,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $1.08B
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email